Involvement Of The Cannabimimetic Compound, N-palmitoyl-ethanolamine, In Inflammatory And Neuropathic Conditions: Review Of The Available Pre-clinical Data, And First Human Studies

Key Findings

These heterogeneous data, together with previous findings reviewed here, substantiate the hypothesis that N-palmitoyl-ethanolamine (PEA) is an endogenous mediator whose levels are increased following neuroinflammatory or neuropathic conditions in both animals and humans, possibly to exert a local anti-inflammatory and analgesic action.

Information and Links

Link: Involvement Of The Cannabimimetic Compound, N-palmitoyl-ethanolamine, In Inflammatory And Neuropathic Conditions: Review Of The Available Pre-clinical Data, And First Human Studies

Year: 2005

DOI: 10.1016/j.neuropharm.2005.01.001